EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Pilot experience of [ 161 Tb]Tb-PSMA-617 RLT in mCRPC patients after conventional PSMA RLT within a prospective registry

Florian Rosar, Caroline Burgard, Christine Petrescu, Arne Blickle, Mark Bartholomä, Stephan Maus, Moritz B Bastian, Tilman Speicher, Andrea Schaefer-Schuler, Samer Ezziddin

Theranostics · 2025

DOI: 10.7150/thno.115831 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Theranostics, 2025. Verfasst von Florian Rosar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Saarland University - Medical Center, Homburg, Germany. Hauptthemen laut MEDLINE: Dipeptides, Heterocyclic Compounds, 1-Ring, Prostatic Neoplasms, Castration-Resistant, Radioisotopes. Die Arbeit wurde bisher 11-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DipeptidesHeterocyclic Compounds, 1-RingProstatic Neoplasms, Castration-ResistantRadioisotopesRadiopharmaceuticalsTerbiumAgedAged, 80 and overHumansMaleMiddle AgedLutetiumPilot ProjectsProspective StudiesRegistriesTreatment OutcomeProstate-Specific Antigen

Stichwörter der Autor:innen

161TbPSMARLTTb-161mCRPCprostate cancerradioligand therapyterbium-161

Substanzen

DipeptidesHeterocyclic Compounds, 1-RingLutetiumPSMA-617RadioisotopesRadiopharmaceuticalsTerbiumProstate-Specific Antigen

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Saarland University - Medical Center, Homburg, Germany.

Zitieren

APA

Rosar, F., Burgard, C., Petrescu, C., Blickle, A., Bartholomä, M., Maus, S., Bastian, M. B., Speicher, T., Schaefer-Schuler, A., & Ezziddin, S. (2025). Pilot experience of [ 161 Tb]Tb-PSMA-617 RLT in mCRPC patients after conventional PSMA RLT within a prospective registry. Theranostics. https://doi.org/10.7150/thno.115831

Vancouver

Rosar F, Burgard C, Petrescu C, Blickle A, Bartholomä M, Maus S, et al. Pilot experience of [ 161 Tb]Tb-PSMA-617 RLT in mCRPC patients after conventional PSMA RLT within a prospective registry. Theranostics. 2025. doi:10.7150/thno.115831

BibTeX
@article{Rosar2025,
  author = {Rosar, Florian and Burgard, Caroline and Petrescu, Christine and Blickle, Arne and Bartholomä, Mark and Maus, Stephan and Bastian, Moritz B and Speicher, Tilman and Schaefer-Schuler, Andrea and Ezziddin, Samer},
  title = {Pilot experience of [ 161 Tb]Tb-PSMA-617 RLT in mCRPC patients after conventional PSMA RLT within a prospective registry},
  journal = {Theranostics},
  year = {2025},
  doi = {10.7150/thno.115831}
}
Kostenlos starten →